Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013)

BACKGROUND: American tegumentary leishmaniasis (ATL) is a non-lethal parasitic disease that presents with cutaneous (CL) and mucosal (ML) clinical forms. ATL treatment aims at healing the lesions and preventing the development of the late mucosal form. Systemic meglumine antimoniate (MA) therapy wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Brahim, Lucia Regina, Valete-Rosalino, Cláudia Maria, Antônio, Liliane de Fátima, Pimentel, Maria Inês Fernandes, Lyra, Marcelo Rosandiski, Paes, Luiz Eduardo de Carvalho, da Costa, Ananda Dutra, Vieira, Iracema Forni, Dias, Cristina Maria Giordano, Duque, Maria Cristina de Oliveira, Marzochi, Mauro Celio de Almeida, Schubach, Armando de Oliveira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719553/
https://www.ncbi.nlm.nih.gov/pubmed/29211245
http://dx.doi.org/10.1590/0074-02760160478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719553/
https://www.ncbi.nlm.nih.gov/pubmed/29211245
http://dx.doi.org/10.1590/0074-02760160478

Ejemplares similares